Navigation Links
Nitiol Stents A Better Alternative for the Conventional Stents

Stents which are mainly used to prevent blocking of various arteries wear away in a short period of time. Hence the patients require other procedures// such as angioplasty or a by pass surgery. The other alternative to stainless steel stents are flexible nickel-titanium tubes.

They are very effective in helping blood flow through thigh arteries clogged by heart disease. Researchers conducted a new study and published it in the New England Journal of Medicine. These nitinol stents provide a better treatment option to patients who suffer severe leg pain from the disease and who are at risk of having a limb amputated.

The advantages of these stents are that they can bend, twist and even regain their shape after being crushed. Martin Schillinger and his co-researchers at the Medical University of Vienna found that patients with the nitinol stents could walk further on a treadmill and had less of a chance of having the tubes clog up again. The study results were that about 37% out of the 51 volunteers suffered new blockage. The risk of breakage of the nitinol stents was just 2 % in the first year. The study used two brands of nitinol stents made by Guidant, which was recently acquired by Boston Scientific. But Alan Hirsch of the University of Minnesota said the Schillinger study is not definitive because it only followed patients for a year and did not include people who were treated without surgery (control group).


'"/>




Page: 1

Related medicine news :

1. Stronger Backing for Drug-Coated Stents
2. Drug-Coated Stents – Proven to be More Effectiv
3. The Efficacy Of Newer Stents Questioned
4. Analyzing The Side Effects Of Sirolimus Stents
5. Stents That Release Medication To Check Artery Narrowing
6. Drug-Coated Stents Work Better In Diabetic Patients After Angioplasty
7. Drug-Eluting Stents Ensure Patency Of The Saphenous Vein Grafts
8. Effectiveness Of Drug-Releasing Coronary Stents
9. Does Life Saving Stents Actually Carry The Risk Of Blood Clots?
10. Bottleneck for Neck Stents - May Enhance Risk of Stroke, Says a Study
11. Using Heart Stents Tends to Form More Clots
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet ... product that was developed to enhance the health of felines. The formula is all-natural ... two main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology: